Ads
related to: blood glucose sensor technology corporation scam- Dexcom Safety Information
Dexcom CGM Indications for Use,
Warnings and Precautions.
- Dexcom All Access Blog
Find Resources, Articles and
Insights For Healthier Living.
- BGM vs. CGM
Discover the Benefits of CGM Versus
BGM for Diabetes Management.
- Accessible & Affordable
Learn More About Cost & Coverage
For The Dexcom G7 CGM System.
- Dexcom Safety Information
Search results
Results From The WOW.Com Content Network
Elizabeth Anne Holmes (born February 3, 1984) is an American biotechnology entrepreneur who was convicted of fraud in connection to her blood-testing company, Theranos. [ 2] The company's valuation soared after it claimed to have revolutionized blood testing by developing methods that needed only very small volumes of blood, such as from a ...
Theranos Inc. (/ ˈ θ ɛr. ə n. oʊ s /) was an American privately held corporation [5] that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $10 billion valuation at its peak in 2013 and 2014.
Noninvasive glucose monitoring ( NIGM ), called Noninvasive continuous glucose monitoring when used as a CGM technique, is the measurement of blood glucose levels, required by people with diabetes to prevent both chronic and acute complications from the disease, without drawing blood, puncturing the skin, or causing pain or trauma.
Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood ( glycemia ). Particularly important in diabetes management, a blood glucose test is typically performed by piercing the skin (typically, via fingerstick) to draw blood, then applying the blood to a chemically active disposable 'test ...
A continuous glucose monitor ( CGM) is a device used for monitoring blood glucose on a continual basis instead of monitoring glucose levels periodically by drawing a drop of blood from a finger. This is known as continuous glucose monitoring. CGMs are used by people who treat their diabetes with insulin, for example people with type 1 diabetes ...
Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. [3] [4] In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours.
The technology that goes into the ICGM system consists of two parts. Primarily is the internal sensor which utilizes chemical reactions to determine blood glucose levels. Additionally, is an external receiver used to display glucose readings and patterns in real-time, hoping to help reduce the level of care needed in diabetics.
For premium support please call: 800-290-4726 more ways to reach us
Ads
related to: blood glucose sensor technology corporation scam